STOCK TITAN

Selectis Health (GBCS) Stock Price, News & Analysis

GBCS

Selectis Health (GBCS) last traded on October 1, 2026. A Form 15-12G filed on October 9, 2026 ends the SEC registration of its shares.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
27 132 sessions, October 1, 2025 to October 1, 2026
Largest daily move
+68.8% close of June 24, 2026
1-year change
+154.7% closing prices, October 1, 2025 to October 1, 2026
1-month change
+0.4% closing prices, September 1, 2026 to October 1, 2026

Company Description

Written before these shares stopped trading.

Selectis Health, Inc. (GBCS) is a healthcare company that owns and/or operates medical care facilities in the United States. According to company disclosures, Selectis Health focuses on healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, with an emphasis on skilled nursing, assisted living, independent living, and related rehabilitation and healthcare services. Its shares trade on the OTC market under the symbol GBCS.

Business focus and facility footprint

Based on recent company announcements, Selectis Health’s footprint centers on skilled nursing facilities, assisted living, and independent living communities. The company has disclosed that its facilities provide living services, speech therapy, occupational therapy, physical therapy, social services, and other rehabilitation and healthcare services. These services are delivered across multiple states, with a focus on the American Southcentral and Southeastern regions.

In various press releases, Selectis Health has summarized its facility footprint at different points in time. Its facilities have included skilled nursing centers in Arkansas, Georgia, Ohio, and Oklahoma, as well as an assisted living facility and an independent living community on a shared campus in Tulsa, Oklahoma. Some facilities are owned and operated directly by Selectis Health or its wholly owned subsidiaries, while others are leased facilities operated by third parties, as indicated in the company’s disclosures.

Strategic emphasis and regional relationships

According to the company’s own description, Selectis Health focuses on building strategic relationships with the local communities in which its facilities are located. The company states that these partnerships are intended to improve the quality of care for facility residents. It has also described a focused growth strategy aimed at deepening its presence in Southcentral and Southeastern U.S. markets to better serve an aging population along a continuum of care that includes skilled nursing, assisted living, and independent living.

Company communications highlight efforts to improve facility operations, patient census, and quality measurement ratings. For example, Selectis Health has discussed operational improvement initiatives at facilities such as Southern Hills in Tulsa, Oklahoma and Park Place in Oklahoma City, Oklahoma, including upgrades to building infrastructure, development of independent living communities, and changes in facility management. The company has also reported improvements in quality measurement ratings as measured by the Centers for Medicare & Medicaid Services (CMS) across certain facilities, including facilities in Georgia and Oklahoma.

Portfolio optimization and real estate transactions

Selectis Health has described an ongoing effort to optimize its facility footprint through real estate transactions. In multiple press releases and Form 8-K filings, the company has reported entering into and completing purchase and sale agreements for certain skilled nursing facilities in Georgia. These transactions have involved the sale of real estate, buildings, improvements, and certain personal property used in facility operations, and in some cases have been accompanied by operations transfer agreements to new operators.

For example, the company has disclosed agreements to sell four skilled nursing facilities in Georgia for an aggregate consideration of $31 million, as well as a separate agreement and subsequent closing for the sale of the Archway Transitional Care Center in Macon, Georgia. In a later announcement, Selectis Health reported a definitive purchase and sale agreement for two additional Georgia skilled nursing facilities, known as Providence of Sparta Health & Rehab and Warrenton Health & Rehabilitation. The company has stated that proceeds from such transactions are expected to enhance its balance sheet, retire existing debt, and provide flexibility in optimizing its remaining facility footprint, although it also notes that completion of pending transactions is subject to customary closing conditions and regulatory approvals.

Operational initiatives and quality measures

Company updates have described various operational initiatives, including efforts to increase patient census, adjust patient mix, and manage costs. Selectis Health has discussed the use of group purchasing organizations (GPOs) and enterprise purchasing software to seek cost savings across its facilities. It has also highlighted internal training programs and facility-level leadership hires intended to support operational efficiency and communication.

In its communications, Selectis Health has emphasized improvements in occupancy and quality at specific facilities. For instance, the company has reported increases in occupancy at its Southern Hills campus in Tulsa and at the Park Place facility in Oklahoma City. It has also referenced improvements in CMS quality measurement ratings at facilities in Georgia and Oklahoma, and has described these ratings as a public scorecard reflecting regulatory compliance, staffing stability, and resident outcomes.

Corporate structure and governance context

Selectis Health, Inc. is incorporated in Utah, as reflected in its SEC filings. The company has reported changes in its leadership and board composition over time through Current Reports on Form 8-K and press releases. These disclosures have included appointments of executive officers and directors, as well as changes in board membership and committee participation. The company has also noted efforts to meet corporate governance requirements associated with potential listing on a major national exchange, while its shares trade on the OTC market.

In addition, Selectis Health has reported entering into financing arrangements, including senior secured promissory notes and related modification agreements. For example, an 8-K filing describes a Third Amended and Restated Allonge and Modification Agreement that extends the maturity date and adjusts terms of certain senior secured promissory notes, and also references warrants previously granted to noteholders.

Geographic and sector positioning

According to its repeated "About Selectis Health" descriptions, the company positions itself within the healthcare sector as an owner and/or operator of healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma. Its stated focus is on serving the aging population in Southcentral and Southeastern U.S. markets through a continuum of care that includes skilled nursing, assisted living, independent living, and rehabilitation services. This places Selectis Health in the medical care facilities industry, with operations tied to long-term care, post-acute care, and related services.

Investor considerations

For investors researching GBCS stock, company press releases and SEC filings provide insight into Selectis Health’s facility portfolio, real estate transactions, financing arrangements, and governance changes. The company has discussed strategic priorities such as improving operational efficiency, optimizing its facility footprint, and managing its capital structure. Because many of these initiatives involve regulatory approvals, real estate transactions, and changes in facility operations, investors often review both news releases and formal filings to understand the company’s progress and obligations.

Stock Performance

$5.73
No recent trading
Last close: October 1, 2026
+154.7%
1 year to October 1, 2026
$17.6M

Selectis Health (GBCS) closed at $5.73 on October 1, 2026. In the 12 months to October 1, 2026, the price gained 154.7%.

See what a $1,000 investment in GBCS would be worth today

Average down calculator for GBCS

GBCS Metrics & Rankings

Market Cap
$17.6M
View ranking

Price returns through October 1, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Financial Highlights

Selectis Health generated $41.4M in revenue in FY2025, operating income reached -$1.6M (-3.8% operating margin), and net income was -$1.0M, reflecting a -2.5% net profit margin. Diluted earnings per share stood at -$0.34. The company generated $1.9M in operating cash flow. The current ratio was 0.30, measuring current assets divided by current liabilities.

$41.4M
Revenue (FY2025)
-$1.0M
Net Income (FY2025)
$1.9M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for GBCS.

Short Interest History

Last 12 Months

Short interest in Selectis Health (GBCS) currently stands at 1.0 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since March 2026, short interest has increased by 928.3%.

Days to Cover History

Last 12 Months

Days to cover for Selectis Health (GBCS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

GBCS Company Profile & Sector Positioning

Selectis Health (GBCS) operates in the Medical Care Facilities industry within the broader Healthcare sector.

Investors comparing GBCS often look at related companies in the same sector, including Syra Health Corp A (SYRA), Elite Health Systems (EHSI), Adia Med Inc (ADIA), Xcelerate Inc (XCRT), and Univec Inc (UNVC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBCS's relative position within its industry.

Frequently Asked Questions

Selectis Health (GBCS) last traded on October 1, 2026. A Form 15-12G filed on October 9, 2026 ends the SEC registration of its shares.

Selectis Health (GBCS) has no recent trading. Its last close was $5.73 on October 1, 2026.

The market cap of Selectis Health (GBCS) is approximately $17.6M. Learn more about what market capitalization means .

The FY2025 revenue of Selectis Health (GBCS) is $41.4M, from its most recent completed fiscal year.

The FY2025 net income of Selectis Health (GBCS) is -$1.0M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Selectis Health (GBCS) is -$0.34 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Selectis Health (GBCS) is $1.9M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Selectis Health (GBCS) is -2.5% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Selectis Health (GBCS) is -3.8% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The current ratio of Selectis Health (GBCS), current assets divided by current liabilities, was 0.30 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Selectis Health (GBCS) is -$1.6M for FY2025, its most recent completed fiscal year. Learn about operating income.